Ads
related to: cancer cell impact factor- EGFRm mNSCLC Progression
What's Next When Patients Progress
On EGFR-TKIs? Visit Site For Info.
- View Possible Approaches
See The Need For Additional Options
In EGFRm mNSCLC. Learn More.
- Addressing The Unmet Need
Learn About The Unmet Need For
Options That Can Improve Outcomes
- A New Line Of Thinking
For When EGFR-TKI Resistance Leads
To Progression in mNSCLC. Read More
- EGFRm mNSCLC Progression
Search results
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of...
Digital Journal· 6 days agoINTASYL drugs precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. For ...
What are processed foods and why are they bad for you? 4 things to know
The Courier Journal via Yahoo News· 7 days agoSo while another cause of death, like cancer, may ultimately be the cause of death, heart disease is...
Matcha extract mouthwash could fight gum disease-causing bacteria
MedicalNewsToday via AOL· 14 hours agoA recent study suggests that a mouthwash containing matcha powder could have antibacterial...
Is BPA Making You Sick?
Mercola· 2 days agoFirst created in 1891 by a Russian chemist, BPA didn't make an appearance in the manufacture of products until the 1950s, when it was used to produce resilient, and often transparent plastics ...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 5 days agoIovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer ...
Summer is here! Your need-to-know sunscreen guide
KHON 2 Honolulu· 2 days agoIt’s National Sunscreen Day, and it’s the unofficial start to summer. So, KHON2.com decided to give you a few pointers on how to select sunscreens for...
Earnings call: Nanobiotix reports Q1 2024 results, advances with NBTXR3
Investing.com· 7 days agoSignificant strides were made in their collaboration with Janssen on the NBTXR3 development plan,...
The bacteria in your mouth are important for your health—four diseases linked to your oral...
Medical Xpress· 6 days agoSince the respiratory tract starts in the mouth and ends in the lungs, it's perhaps not surprising...
SLAS Technology Presents: Advances in Synthetic Bi | Newswise
Newswise· 7 days agoVolume 29, Issue 2 of SLAS Technology, includes three original research articles covering skin...
... for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer...
WROC Rochester· 6 days agoThe data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical Oncology ...